{
  "document": {
    "category": "csaf_security_advisory",
    "csaf_version": "2.0",
    "distribution": {
      "text": "Disclosure is not limited",
      "tlp": {
        "label": "WHITE",
        "url": "https://us-cert.cisa.gov/tlp/"
      }
    },
    "lang": "en-US",
    "notes": [
      {
        "category": "legal_disclaimer",
        "text": "All information products included in https://us-cert.cisa.gov/ics are provided \"as is\" for informational purposes only. The Department of Homeland Security (DHS) does not provide any warranties of any kind regarding any information contained within. DHS does not endorse any commercial product or service, referenced in this product or otherwise. Further dissemination of this product is governed by the Traffic Light Protocol (TLP) marking in the header. For more information about TLP, see https://us-cert.cisa.gov/tlp/.",
        "title": "Legal Notice"
      },
      {
        "category": "general",
        "text": "This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov",
        "title": "CISA Disclaimer"
      },
      {
        "category": "general",
        "text": "CISA recommends users take defensive measures to minimize the risk of exploitation.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Minimize network exposure for all control system devices and/or systems, ensuring they are not accessible from the internet.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Locate control system networks and remote devices behind firewalls and isolating them from business networks.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "When remote access is required, use more secure methods, such as Virtual Private Networks (VPNs). Recognize VPNs may have vulnerabilities, should be updated to the most recent version available, and are only as secure as the connected devices.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "CISA reminds organizations to perform proper impact analysis and risk assessment prior to deploying defensive measures.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "CISA also provides a section for control systems security recommended practices on the ICS webpage on cisa.gov. Several CISA products detailing cyber defense best practices are available for reading and download, including Improving Industrial Control Systems Cybersecurity with Defense-in-Depth Strategies.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "CISA encourages organizations to implement recommended cybersecurity strategies for proactive defense of ICS assets.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Additional mitigation guidance and recommended practices are publicly available on the ICS webpage at cisa.gov in the technical information paper, ICS-TIP-12-146-01B--Targeted Cyber Intrusion Detection and Mitigation Strategies.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "Organizations observing suspected malicious activity should follow established internal procedures and report findings to CISA for tracking and correlation against other incidents.",
        "title": "Recommended Practices"
      },
      {
        "category": "general",
        "text": "CISA also recommends users take the following measures to protect themselves from social engineering attacks: Do not click web links or open attachments in unsolicited email messages. Refer to Recognizing and Avoiding Email Scams for more information on avoiding email scams. Refer to Avoiding Social Engineering and Phishing Attacks for more information on social engineering attacks.",
        "title": "Recommended Practices"
      }
    ],
    "publisher": {
      "category": "coordinator",
      "contact_details": "central@cisa.dhs.gov",
      "name": "CISA",
      "namespace": "https://www.cisa.gov/"
    },
    "references": [
      {
        "category": "self",
        "summary": "ICS Advisory ICSA-15-161-01 JSON",
        "url": "https://raw.githubusercontent.com/cisagov/CSAF/develop/csaf_files/OT/white/2015/icsa-15-161-01.json"
      },
      {
        "category": "self",
        "summary": "ICS Advisory ICSA-15-161-01 - Web Version",
        "url": "https://www.cisa.gov/news-events/ics-advisories/icsa-15-161-01"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/uscert/ics/alerts/ICS-ALERT-10-301-01"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/resources-tools/resources/ics-recommended-practices"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/topics/industrial-control-systems"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://us-cert.cisa.gov/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/sites/default/files/publications/Cybersecurity_Best_Practices_for_Industrial_Control_Systems.pdf"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/uscert/ics/tips/ICS-TIP-12-146-01B"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/uscert/sites/default/files/publications/emailscams0905.pdf"
      },
      {
        "category": "external",
        "summary": "Recommended Practices",
        "url": "https://www.cisa.gov/uscert/ncas/tips/ST04-014"
      }
    ],
    "title": "Hospira Plum A+ and Symbiq Infusion Systems Vulnerabilities",
    "tracking": {
      "current_release_date": "2025-06-06T16:08:42.194031Z",
      "generator": {
        "date": "2025-06-06T16:08:42.193971Z",
        "engine": {
          "name": "CISA CSAF Generator",
          "version": "1.0.0"
        }
      },
      "id": "ICSA-15-161-01",
      "initial_release_date": "2015-03-13T06:00:00.000000Z",
      "revision_history": [
        {
          "date": "2015-03-13T06:00:00.000000Z",
          "legacy_version": "Initial",
          "number": "1",
          "summary": "Initial Publication"
        },
        {
          "date": "2025-06-06T16:08:42.194031Z",
          "legacy_version": "CSAF Conversion",
          "number": "2",
          "summary": "Advisory converted into a CSAF"
        }
      ],
      "status": "final",
      "version": "2"
    }
  },
  "product_tree": {
    "branches": [
      {
        "branches": [
          {
            "branches": [
              {
                "category": "product_version_range",
                "name": "<=13.4",
                "product": {
                  "name": "Hospira Plum A+ Infusion System: <=13.4",
                  "product_id": "CSAFPID-0001"
                }
              }
            ],
            "category": "product_name",
            "name": "Plum A+ Infusion System"
          },
          {
            "branches": [
              {
                "category": "product_version_range",
                "name": "<=13.6",
                "product": {
                  "name": "Hospira Plum A+3 Infusion System: <=13.6",
                  "product_id": "CSAFPID-0002"
                }
              }
            ],
            "category": "product_name",
            "name": "Plum A+3 Infusion System"
          },
          {
            "branches": [
              {
                "category": "product_version_range",
                "name": "<=3.13",
                "product": {
                  "name": "Hospira Symbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. According to Hospira, during a recent service visit, the remaining Symbiq Infusion Systems have had Port 20/FTP and Port 23/TELNET closed: <=3.13",
                  "product_id": "CSAFPID-0003"
                }
              }
            ],
            "category": "product_name",
            "name": "Symbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. According to Hospira, during a recent service visit, the remaining Symbiq Infusion Systems have had Port 20/FTP and Port 23/TELNET closed"
          }
        ],
        "category": "vendor",
        "name": "Hospira"
      }
    ]
  },
  "vulnerabilities": [
    {
      "cve": "CVE-2015-3952",
      "cwe": {
        "id": "CWE-312",
        "name": "Cleartext Storage of Sensitive Information"
      },
      "notes": [
        {
          "category": "summary",
          "text": "Wireless keys are stored in plain text on Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002",
          "CSAFPID-0003"
        ]
      },
      "remediations": [
        {
          "category": "mitigation",
          "details": "Hospira is communicating with customers to direct them to close Port 20/FTP and Port 23/TELNET on the affected devices. In addition, Hospira is also releasing its Plum 360 Infusion System. Hospira asserts that the Plum 360 uses a different architecture than the Plum A+ Infusion System and is not vulnerable to the reported vulnerabilities.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        },
        {
          "category": "mitigation",
          "details": "For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ],
      "scores": [
        {
          "cvss_v2": {
            "baseScore": 6.4,
            "vectorString": "AV:N/AC:L/Au:N/C:P/I:P/A:N",
            "version": "2.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2015-3953",
      "cwe": {
        "id": "CWE-259",
        "name": "Use of Hard-coded Password"
      },
      "notes": [
        {
          "category": "summary",
          "text": "Hard-coded accounts may be used to access Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002",
          "CSAFPID-0003"
        ]
      },
      "remediations": [
        {
          "category": "mitigation",
          "details": "Hospira is communicating with customers to direct them to close Port 20/FTP and Port 23/TELNET on the affected devices. In addition, Hospira is also releasing its Plum 360 Infusion System. Hospira asserts that the Plum 360 uses a different architecture than the Plum A+ Infusion System and is not vulnerable to the reported vulnerabilities.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        },
        {
          "category": "mitigation",
          "details": "For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ],
      "scores": [
        {
          "cvss_v2": {
            "baseScore": 10.0,
            "vectorString": "AV:N/AC:L/Au:N/C:C/I:C/A:C",
            "version": "2.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2015-3954",
      "cwe": {
        "id": "CWE-285",
        "name": "Improper Authorization"
      },
      "notes": [
        {
          "category": "summary",
          "text": "Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior give unauthenticated users root privileges on Port 23/TELNET by default. An unauthorized user could issue commands to the pump. Hospira recommends that customers close Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002",
          "CSAFPID-0003"
        ]
      },
      "remediations": [
        {
          "category": "mitigation",
          "details": "Hospira is communicating with customers to direct them to close Port 20/FTP and Port 23/TELNET on the affected devices. In addition, Hospira is also releasing its Plum 360 Infusion System. Hospira asserts that the Plum 360 uses a different architecture than the Plum A+ Infusion System and is not vulnerable to the reported vulnerabilities.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        },
        {
          "category": "mitigation",
          "details": "For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ],
      "scores": [
        {
          "cvss_v2": {
            "baseScore": 10.0,
            "vectorString": "AV:N/AC:L/Au:N/C:C/I:C/A:C",
            "version": "2.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2015-3955",
      "cwe": {
        "id": "CWE-121",
        "name": "Stack-based Buffer Overflow"
      },
      "notes": [
        {
          "category": "summary",
          "text": "Stack-based buffer overflow in Hospira LifeCare PCA Infusion System 5.0 and earlier, and possibly other versions, allows remote attackers to execute arbitrary code via unspecified vectors.",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002",
          "CSAFPID-0003"
        ]
      },
      "remediations": [
        {
          "category": "mitigation",
          "details": "Hospira is communicating with customers to direct them to close Port 20/FTP and Port 23/TELNET on the affected devices. In addition, Hospira is also releasing its Plum 360 Infusion System. Hospira asserts that the Plum 360 uses a different architecture than the Plum A+ Infusion System and is not vulnerable to the reported vulnerabilities.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        },
        {
          "category": "mitigation",
          "details": "For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ],
      "scores": [
        {
          "cvss_v2": {
            "baseScore": 7.6,
            "vectorString": "AV:N/AC:H/Au:N/C:C/I:C/A:C",
            "version": "2.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2015-3956",
      "cwe": {
        "id": "CWE-345",
        "name": "Insufficient Verification of Data Authenticity"
      },
      "notes": [
        {
          "category": "summary",
          "text": "Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior accept drug libraries, firmware updates, pump commands, and unauthorized configuration changes from unauthenticated devices on the host network. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002",
          "CSAFPID-0003"
        ]
      },
      "remediations": [
        {
          "category": "mitigation",
          "details": "Hospira is communicating with customers to direct them to close Port 20/FTP and Port 23/TELNET on the affected devices. In addition, Hospira is also releasing its Plum 360 Infusion System. Hospira asserts that the Plum 360 uses a different architecture than the Plum A+ Infusion System and is not vulnerable to the reported vulnerabilities.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        },
        {
          "category": "mitigation",
          "details": "For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ],
      "scores": [
        {
          "cvss_v2": {
            "baseScore": 7.6,
            "vectorString": "AV:N/AC:H/Au:N/C:C/I:C/A:C",
            "version": "2.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2015-3957",
      "cwe": {
        "id": "CWE-321",
        "name": "Use of Hard-coded Cryptographic Key"
      },
      "notes": [
        {
          "category": "summary",
          "text": "Hospira LifeCare PCA Infusion System before 7.0 stores private keys and certificates, which has unspecified impact and attack vectors.",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002",
          "CSAFPID-0003"
        ]
      },
      "remediations": [
        {
          "category": "mitigation",
          "details": "Hospira is communicating with customers to direct them to close Port 20/FTP and Port 23/TELNET on the affected devices. In addition, Hospira is also releasing its Plum 360 Infusion System. Hospira asserts that the Plum 360 uses a different architecture than the Plum A+ Infusion System and is not vulnerable to the reported vulnerabilities.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        },
        {
          "category": "mitigation",
          "details": "For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ],
      "scores": [
        {
          "cvss_v2": {
            "baseScore": 4.6,
            "vectorString": "AV:L/AC:L/Au:N/C:P/I:P/A:P",
            "version": "2.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ]
    },
    {
      "cve": "CVE-2015-3958",
      "cwe": {
        "id": "CWE-400",
        "name": "Uncontrolled Resource Consumption"
      },
      "notes": [
        {
          "category": "summary",
          "text": "Hospira LifeCare PCA Infusion System 5.0 and earlier, and possibly other versions, allows remote attackers to cause a denial of service (forced manual reboot) via a flood of TCP packets.",
          "title": "Vulnerability Summary"
        }
      ],
      "product_status": {
        "known_affected": [
          "CSAFPID-0001",
          "CSAFPID-0002",
          "CSAFPID-0003"
        ]
      },
      "remediations": [
        {
          "category": "mitigation",
          "details": "Hospira is communicating with customers to direct them to close Port 20/FTP and Port 23/TELNET on the affected devices. In addition, Hospira is also releasing its Plum 360 Infusion System. Hospira asserts that the Plum 360 uses a different architecture than the Plum A+ Infusion System and is not vulnerable to the reported vulnerabilities.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        },
        {
          "category": "mitigation",
          "details": "For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.",
          "product_ids": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ],
      "scores": [
        {
          "cvss_v2": {
            "baseScore": 7.8,
            "vectorString": "AV:N/AC:L/Au:N/C:N/I:N/A:C",
            "version": "2.0"
          },
          "products": [
            "CSAFPID-0001",
            "CSAFPID-0002",
            "CSAFPID-0003"
          ]
        }
      ]
    }
  ]
}